vers la météo de la validation par utilisateur
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------------OBJ:V-N------------------------+ | | | | +-----------COMP:N-N(of)----------+ | | +--------------SUBJ:V-N--------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ | | +----COMP:N-N(of)---+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ +COMP:V-N(by+ +MOD_+MOD_ATT:N-N+ +MOD_ATT+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,@card@) MOD_ATT:N-ADJ (percent,@card@) MOD_ATT:N-N (expression,percent) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,@card@) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------------OBJ:V-N------------------------+ | | | +-----------------OBJ:V-N----------------+ | | +--------------SUBJ:V-N--------------+ | | | | +-----------COMP:N-N(of)----------+ | | +-----------SUBJ:V-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ | | +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ +COMP:V-N(by+ +MOD_+MOD_ATT:N-N+ +MOD_ATT+ | +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,@card@) MOD_ATT:N-ADJ (percent,@card@) MOD_ATT:N-N (expression,percent) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) OBJ:V-N (increase,@card@) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------------OBJ:V-N------------------------+ | | | +-----------COMP:N-N(of)----------+ | | +--------------SUBJ:V-N--------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ | | +----COMP:N-N(of)---+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ +COMP:V-N(by+ +MOD_+MOD_ATT:N-N+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,@card@) MOD_ATT:N-ADJ (percent,@card@) MOD_ATT:N-N (expression,percent) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,@card@) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------------OBJ:V-N------------------------+ | | | | +-----------COMP:N-N(of)----------+ | | +--------------SUBJ:V-N--------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ | | +----COMP:N-N(of)---+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ +COMP:V-N(by+ +MOD_+MOD_ATT:N-N+ +MOD_ATT+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,@card@) MOD_ATT:N-ADJ (percent,@card@) MOD_ATT:N-N (expression,percent) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,@card@) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------OBJ:V-N------------------------+ | | +-----------------OBJ:V-N----------------+ | | +--------------SUBJ:V-N--------------+ | | | +-----------COMP:N-N(of)----------+ | | +-----------SUBJ:V-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ | | +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ +COMP:V-N(by+ +MOD_+MOD_ATT:N-N+ +MOD_ATT+ | +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,@card@) MOD_ATT:N-ADJ (percent,@card@) MOD_ATT:N-N (expression,percent) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) OBJ:V-N (increase,@card@) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------------COMP:N-N(of)---------------+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------------COMP:N-N(of)---------------+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------------COMP:N-N(of)---------------+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------------COMP:N-N(of)---------------+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------COMP:N-N(by)---------+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------------COMP:N-N(of)---------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------COMP:N-N(by)---------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---------------OBJ:V-N--------------+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------COMP:N-N(by)---------+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------COMP:N-N(by)---------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---------------OBJ:V-N--------------+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---------------OBJ:V-N--------------+ | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------COMP:N-N(by)---------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---------------OBJ:V-N--------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---------------OBJ:V-N--------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---------------OBJ:V-N--------------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------------COMP:N-N(of)---------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------COMP:N-N(by)---------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------COMP:N-N(by)---------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---------------OBJ:V-N--------------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------------COMP:N-N(of)---------------+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------------COMP:N-N(of)---------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------------COMP:N-N(of)---------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------------COMP:N-N(of)---------------+ | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------------COMP:N-N(of)---------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------------COMP:N-N(of)---------------+ | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-----------------OBJ:V-N----------------+ | +------------SUBJ:V_PASS-N-----------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +------------SUBJ:V_PASS-N-----------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +------------SUBJ:V_PASS-N-----------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-----------------OBJ:V-N----------------+ | +------------SUBJ:V_PASS-N-----------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-----------------OBJ:V-N----------------+ | +------------SUBJ:V_PASS-N-----------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +------------SUBJ:V_PASS-N-----------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------------COMP:N-N(of)---------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +------------SUBJ:V_PASS-N-----------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +------------SUBJ:V_PASS-N-----------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +------------SUBJ:V_PASS-N-----------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+-----------------------------------COMP:V-N(by)-----------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +------------SUBJ:V_PASS-N-----------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------COMP:N-N(by)---------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +---------------COMP:N-N(of)---------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------COMP:N-N(by)---------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(of)-------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (__SP__,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------------COMP:N-N(of)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (__SP__,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------COMP:N-N(by)---------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------COMP:N-N(by)---------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------COMP:N-N(by)---------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------COMP:N-N(by)---------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | +-----------------OBJ:V-N----------------+ | +------------SUBJ:V_PASS-N-----------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(of)-------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (__SP__,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------------COMP:N-N(of)-------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (__SP__,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------------COMP:N-N(of)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (__SP__,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +---------------COMP:N-N(of)---------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------COMP:N-N(by)---------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +---------------COMP:N-N(of)---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------COMP:N-N(by)---------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------------COMP:N-N(of)---------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------COMP:N-N(by)---------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------------COMP:N-N(of)---------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------COMP:N-N(by)---------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------COMP:N-N(by)---------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------COMP:N-N(by)---------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------COMP:N-N(by)---------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---------------OBJ:V-N--------------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | | +-----------------OBJ:V-N----------------+ | +------------SUBJ:V_PASS-N-----------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+ | | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---------------OBJ:V-N--------------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | +-----------------OBJ:V-N----------------+ | +------------SUBJ:V_PASS-N-----------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------------COMP:N-N(of)---------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------COMP:N-N(by)---------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------COMP:N-N(by)---------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------COMP:N-N(by)---------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---------------OBJ:V-N--------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(of)-------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (__SP__,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +---------------COMP:N-N(of)---------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------COMP:N-N(by)---------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) SUBJ:V-N (be,__NODE__) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------------COMP:N-N(of)-------------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------COMP:N-N(by)---------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V_PASS-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +------------SUBJ:V_PASS-N-----------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +------------SUBJ:V_PASS-N-----------+ | | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+ | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +------------SUBJ:V_PASS-N-----------+ | | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------SUBJ:V-N-----------+ | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+------------SUBJ:V_PASS-N-----------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(of)-------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---------------OBJ:V-N--------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------COMP:N-N(of)-------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------COMP:N-N(by)-------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(of)-------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------COMP:N-N(by)-------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------COMP:N-N(by)-------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) COMP:N-N(by) (__SP__,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(of)-------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(of)-------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------COMP:N-N(by)-------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) COMP:N-N(by) (__SP__,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-----------------OBJ:V-N----------------+ | | +-------------COMP:N-N(by)-------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) COMP:N-N(by) (__SP__,deprivation) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(by)-------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------------COMP:N-N(of)-------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---------------OBJ:V-N--------------+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-------------------COMP:N-N(of)-------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------COMP:N-N(by)-------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(of)-------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---------------OBJ:V-N--------------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +---------OBJ:V-N--------+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) COMP:N-N(by) (__SP__,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---------------OBJ:V-N--------------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---------------OBJ:V-N--------------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | +-------------COMP:N-N(by)-------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) COMP:N-N(by) (__SP__,deprivation) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | +-------------COMP:N-N(by)-------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) COMP:N-N(by) (__SP__,deprivation) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(by)-------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+---------------OBJ:V-N--------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------------COMP:N-N(of)-------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------COMP:N-N(by)-------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---------------OBJ:V-N--------------+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,expression) SUBJ:V-N (increase,__NODE__)
